{"id":"W4407205140","doi":"10.1016/j.vaccine.2025.126847","title":"A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults","year":2025,"lang":"en","type":"article","venue":"Vaccine","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"Micropharma (Canada)","funders":"Moderna","keywords":"Immunogenicity; Virology; Randomized controlled trial; Medicine; Seasonal influenza; Influenza vaccine; Vaccination; Immunology; Coronavirus disease 2019 (COVID-19); Internal medicine; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859456,0.0002822484,0.001703683,0.0005222048,0.00008781644,0.00001222549,0.0001498243,0.0001436297,0.0001897011],"category_scores_gemma":[0.004354507,0.0002138307,0.0002402224,0.0007860952,0.00005399054,0.000106646,0.0002594442,0.0004493821,0.000007804668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001225207,"about_ca_system_score_gemma":0.0002699636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005066546,"about_ca_topic_score_gemma":0.0001324091,"domain_scores_codex":[0.9972925,0.0002861492,0.001195815,0.0003938828,0.0004000567,0.0004316031],"domain_scores_gemma":[0.9979799,0.0008928278,0.0002014538,0.0004437244,0.0003583029,0.000123752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9745722,0.001188859,0.007132877,0.0004163572,0.0005838223,0.00002854284,0.0003217841,0.000003758092,0.002990518,0.0003327906,0.0004271075,0.01200138],"study_design_scores_gemma":[0.9727223,0.001154014,0.01682528,0.000726025,0.0002196249,0.000006955208,0.00007350583,0.001052155,0.002703404,0.0001713126,0.004195352,0.0001500679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856737,0.008183286,0.00006750717,0.00144213,0.0001414418,0.002983432,0.00004918289,0.00004377458,0.001415521],"genre_scores_gemma":[0.9950294,0.003036885,0.0003062024,0.0007585762,0.0001473913,0.0001570155,0.00002362961,0.00002181643,0.0005190423],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01185131,"threshold_uncertainty_score":0.8719763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02499488043643745,"score_gpt":0.3720539233956416,"score_spread":0.3470590429592041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}